Papers authored by Dhanasekaran SM

Collect these papers and discover other ones on Labmeeting. Learn more.
An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancer.
+ cite this
+ View Abstract
Wang XS, Prensner JR, Chen G, Cao Q, Han B, Dhanasekaran SM, Ponnala R, Cao X, Varambally S, Thomas DG, Giordano TJ, Beer DG, Palanisamy N, Sartor MA, Omenn GS, and Chinnaiyan AM
Nature biotechnology 27(11):1005-11, 2009 Nov - Who cited this? | PubMed ID: 19881495 | Fulltext
Recommend
New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites.
+ cite this
+ View Abstract
Lee I, Ajay SS, Yook JI, Kim HS, Hong SH, Kim NH, Dhanasekaran SM, Chinnaiyan AM, and Athey BD
Genome research 19(7):1175-83, 2009 Jul - Who cited this? | PubMed ID: 19336450 | Fulltext
Recommend
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer.
+ cite this
+ View Abstract
Varambally S, Laxman B, Mehra R, Cao Q, Dhanasekaran SM, Tomlins SA, Granger J, Vellaichamy A, Sreekumar A, Yu J, Gu W, Shen R, Ghosh D, Wright LM, Kladney RD, Kuefer R, 
 (show remaining authors)
Neoplasia (New York, N.Y.) 10(11):1285-94, 2008 Nov - Who cited this? | PubMed ID: 18953438 | Fulltext
Recommend
Repression of E-cadherin by the polycomb group protein EZH2 in cancer.
+ cite this
+ View Abstract
Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, Tomlins SA, Mehra R, Laxman B, Cao X, Yu J, Kleer CG, Varambally S, and Chinnaiyan AM
Oncogene, 2008 Sep 22 - Who cited this? | PubMed ID: 18806826 | Fulltext
Recommend
A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.
+ cite this
+ View Abstract
Han B, Mehra R, Dhanasekaran SM, Yu J, Menon A, Lonigro RJ, Wang X, Gong Y, Wang L, Shankar S, Laxman B, Shah RB, Varambally S, Palanisamy N, Tomlins SA, Kumar-Sinha C, 
 (show remaining authors)
Cancer research 68(18):7629, 2008 Sep 15 - Who cited this? | PubMed ID: 18794152 | Fulltext
Recommend
Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer.
+ cite this
+ View Abstract
Yu J, Cao Q, Mehra R, Laxman B, Yu J, Tomlins SA, Creighton CJ, Dhanasekaran SM, Shen R, Chen G, Morris DS, Marquez VE, Shah RB, Ghosh D, Varambally S, and Chinnaiyan AM
Cancer cell 12(5):419, 2007 Nov - Who cited this? | PubMed ID: 17996646 | Fulltext
Recommend
Integrative analysis of genomic aberrations associated with prostate cancer progression.
+ cite this
+ View Abstract
Kim JH, Dhanasekaran SM, Mehra R, Tomlins SA, Gu W, Yu J, Kumar-Sinha C, Cao X, Dash A, Wang L, Ghosh D, Shedden K, Montie JE, Rubin MA, Pienta KJ, Shah RB, 
 (show remaining authors)
Cancer research 67(17):8229-39, 2007 Sep 1 - Who cited this? | PubMed ID: 17804737 | Fulltext
Recommend
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
+ cite this
+ View Abstract
Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, Menon A, Jing X, Cao Q, Han B, Yu J, Wang L, Montie JE, Rubin MA, Pienta KJ, Roulston D, 
 (show remaining authors)
Nature 448(7153):595-9, 2007 Aug 2 - Who cited this? | PubMed ID: 17671502 | Fulltext
Recommend
Feature selection and molecular classification of cancer using genetic programming.
+ cite this
+ View Abstract
Yu J, Yu J, Almal AA, Dhanasekaran SM, Ghosh D, Worzel WP, and Chinnaiyan AM
Neoplasia (New York, N.Y.) 9(4):292-303, 2007 Apr - Who cited this? | PubMed ID: 17460773 | Fulltext
Recommend
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.
+ cite this
+ View Abstract
Mertz KD, Setlur SR, Dhanasekaran SM, Demichelis F, Perner S, Tomlins S, Tchinda J, Laxman B, Vessella RL, Beroukhim R, Lee C, Chinnaiyan AM, and Rubin MA
Neoplasia (New York, N.Y.) 9(3):200, 2007 Mar - Who cited this? | PubMed ID: 17401460 | Fulltext
Recommend
Integrative molecular concept modeling of prostate cancer progression.
+ cite this
+ View Abstract
Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, Dhanasekaran SM, Kalyana-Sundaram S, Wei JT, Rubin MA, Pienta KJ, Shah RB, and Chinnaiyan AM
Nature genetics 39(1):41-51, 2007 Jan - Who cited this? | PubMed ID: 17173048 | Fulltext
Recommend
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
+ cite this
+ View Abstract
Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, and Chinnaiyan AM
Science (New York, N.Y.) 310(5748):644-8, 2005 Oct 28 - Who cited this? | PubMed ID: 16254181 | Fulltext
Recommend
Molecular profiling of human prostate tissues: insights into gene expression patterns of prostate development during puberty.
+ cite this
+ View Abstract
Dhanasekaran SM, Dash A, Yu J, Maine IP, Laxman B, Tomlins SA, Creighton CJ, Menon A, Rubin MA, and Chinnaiyan AM
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 19(2):243, 2005 Feb - Who cited this? | PubMed ID: 15548588 | Fulltext
Recommend
FIZZ1 stimulation of myofibroblast differentiation.
+ cite this
+ View Abstract
Liu T, Dhanasekaran SM, Jin H, Hu B, Tomlins SA, Chinnaiyan AM, and Phan SH
The American journal of pathology 164(4):1315-26, 2004 Apr - Who cited this? | PubMed ID: 15039219 | Fulltext
Recommend
A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell lines.
+ cite this
+ View Abstract
Chay CH, Cooper CR, Gendernalik JD, Dhanasekaran SM, Chinnaiyan AM, Rubin MA, Schmaier AH, and Pienta KJ
Urology 60(5):760-5, 2002 Nov - Who cited this? | PubMed ID: 12429291 | Fulltext
Recommend
The polycomb group protein EZH2 is involved in progression of prostate cancer.
+ cite this
+ View Abstract
Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, and Chinnaiyan AM
Nature 419(6907):624-9, 2002 Oct 10 - Who cited this? | PubMed ID: 12374981 | Fulltext
Recommend
alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
+ cite this
+ View Abstract
Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, Pienta KJ, Ghosh D, and Chinnaiyan AM
JAMA : the journal of the American Medical Association 287(13):1662, 2002 Apr 3 - Who cited this? | PubMed ID: 11926890 | Fulltext
Recommend
Delineation of prognostic biomarkers in prostate cancer.
+ cite this
+ View Abstract
Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, and Chinnaiyan AM
Nature 412(6849):822-6, 2001 Aug 23 - Who cited this? | PubMed ID: 11518967 | Fulltext
Recommend
Isolation and characterization of a transforming growth factor-beta Type II receptor cDNA from Xenopus laevis.
+ cite this
+ View Abstract
Dhanasekaran SM, Vempati UD, and Kondaiah P
Gene 263(1-2):171-8, 2001 Jan 24 - Who cited this? | PubMed ID: 11223255 | Fulltext
Recommend



Search Google Scholar for Dhanasekaran SM

Join Labmeeting

  • Organize and search your PDF collection
  • Collect papers
  • Search millions of papers
  • Keep up to date with paper alerts
  • Read your papers from anywhere
  • Recommend papers to colleagues
  • Manage your lab
Sign Up

Join Labmeeting

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.